AntiCorruption Messaging Faces Headwinds from Lawmaker Stock Trading Scrutiny 13 BSE 500 Stocks Log FiveDay Losing Streak Despite Sensex Gains WasteBar Food Truck Turns Cigarette Butts into Currency A Novel Approach to Plastic Waste Reduction Middle East Conflict Tests Gulf States AI Hub Ambitions Berkshire Hathaway Rebuilds Airline Exposure with 26 Billion Delta Air Lines Stake Sebi Uncovers PumpandDump Scheme Using Social Media to Inflate 82 SME Stocks SMPL Q1 2026 Earnings EPS Beat Drives Positive Market Reaction Despite Revenue Uncertainty Movado Group Q1 2026 Earnings Massive EPS Beat Drives Stock Higher GH Q1 2026 Earnings EPS Beats Estimates Amidst Focus on Precision Oncology Firefly Aerospace Inc FLY Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Surge SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment TRN Q1 2026 Earnings EPS Surprises to the Upside Despite Market Skepticism HealthEquity HQY Shows Modest Gains After Support Test Kura Oncology Stock Slides Testing Key Support Levels Amid Biotech Sector Weakness Spring Valley Acquisition Warrants Slide 6 as SPAC Market Sentiment Weakens Enlivex Surges 1287 as Biotech Stock Breaks Above Key Support Levels Fifth Era Acquisition Corp I Rights FERAR Faces Selling Pressure Tests Key Support at 028 Dating Startups Aim to Eliminate Fake Profiles A New Wave of Authenticity INOD Q1 2026 Earnings Massive EPS Beat Drives Investor Skepticism Flowserve FLS Gains 128 as Technical Levels Point to Potential Upside Atlanta Braves Holdings Inc Series C BATRK Q1 2026 Earnings EPS Beat Estimates Despite Negative Quarter DHI Group Q1 2026 Earnings EPS Surges Past Estimates Stock Jumps 63 CAPL Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiencies MTRX Q1 2026 Earnings Strong EPS Beat Drives Investor Optimism PetMed Express PETS Q1 2026 Earnings Massive EPS Miss Shocks Market Despite Positive Stock Reaction IMPPP Q1 2026 Earnings Preferred EPS Surges Past Estimates on Strong Operating Performance OLMA Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Pipeline Advances